Regeneron Pharmaceuticals, Inc. (REGN): Weighted Average Diluted Shares
108.60M
Year ended 2025-12-31
-1.5%
3-year compound annual growth
-1.2%
5-year compound annual growth
-0.6%
10-year compound annual growth
| Period ended | Weighted Average Diluted Shares | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | 108.60M | -5.6% | 2026-02-04, From 2025-01-01 |
| 2024-12-31 | 115.10M | +1.2% | 2026-02-04, From 2024-01-01 |
| 2023-12-31 | 113.70M | +0.2% | 2026-02-04, From 2023-01-01 |
| 2022-12-31 | 113.50M | +1.2% | 2025-02-05, From 2022-01-01 |
| 2021-12-31 | 112.20M | -2.5% | 2024-02-05, From 2021-01-01 |
| 2020-12-31 | 115.10M | +0.4% | 2023-02-06, From 2020-01-01 |
| 2019-12-31 | 114.60M | -0.2% | 2022-02-07, From 2019-01-01 |
| 2018-12-31 | 114.80M | -0.9% | 2021-02-08, From 2018-01-01 |
| 2017-12-31 | 115.90M | -0.3% | 2020-02-07, From 2017-01-01 |
| 2016-12-31 | 116.30M | +0.9% | 2019-02-07, From 2016-01-01 |
| 2015-12-31 | 115.23M | +1.6% | 2018-02-08, From 2015-01-01 |
| 2014-12-31 | 113.41M | +1.9% | 2017-02-09, From 2014-01-01 |
| 2013-12-31 | 111.29M | -3.5% | 2016-02-11, From 2013-01-01 |
| 2012-12-31 | 115.38M | +27.3% | 2015-02-12, From 2012-01-01 |
| 2011-12-31 | 90.61M | +9.3% | 2014-02-13, From 2011-01-01 |
| 2010-12-31 | 82.93M | n/a | 2013-02-15, From 2010-01-01 |